Zoledronic Acid 4 mg/5mL (Zoledronic Acid INJECTION, SOLUTION, CONCENTRATE) 4 mg/5mL

Zoledronic Acid works by inhibiting osteoclast-mediated bone resorption. It binds to hydroxyapatite in bone tissue and induces osteoclast apoptosis, which helps to lower blood calcium levels and reduce bone pain and fractures. This action is crucial in managing conditions like hypercalcemia and bone metastases.

The dosage of Zoledronic Acid 4 mg/5mL is determined by a healthcare professional based on the patient's medical condition and response to treatment. It is typically administered as a single intravenous infusion over at least 15 minutes. The specific dosage and frequency will be tailored to the individual patient's needs.

Zoledronic Acid is not recommended for use during pregnancy or breastfeeding. It is classified as a pregnancy category X drug, meaning it should be avoided during pregnancy due to potential harm to the fetus. The effects on infants during breastfeeding are not well understood, so it is best to avoid use during this period.

To order Zoledronic Acid 4 mg/5mL from GNH India, submit an enquiry on the product page at gnhindia.com with the required quantity. GNH India supplies hospitals, pharmacies, and procurement teams across international markets. The team will ask you to confirm your trade or institutional credentials and will then provide pricing, availability, shipping (including cold-chain where relevant), and the necessary import paperwork.

Zoledronic Acid is a potent bisphosphonate with a longer duration of action compared to other bisphosphonates like pamidronate. It is often preferred for its convenience and efficacy in managing bone-related complications. However, the choice of bisphosphonate depends on the specific condition being treated and the patient's individual needs.

Zoledronic Acid 4 mg/5mL should be stored at 2-8°C, refrigerated, and protected from light. It should not be frozen or shaken. Proper storage is essential to maintain the medication's efficacy and safety. Always follow the storage instructions provided by the manufacturer and healthcare professional.

Zoledronic Acid 4 mg/5mL is administered as an intravenous infusion over at least 15 minutes. It should be given by healthcare professionals experienced in the administration of intravenous bisphosphonates. The infusion should be administered as a single dose using a separate system and should not be mixed with solutions containing calcium ions.

The most serious risks associated with Zoledronic Acid 4 mg/5mL include osteonecrosis of the jaw, kidney problems, and severe bone, joint, or muscle pain. Patients should be monitored for these risks, and any symptoms should be reported to a healthcare professional immediately. Regular dental check-ups and monitoring of kidney function are recommended.

Zoledronic Acid 4 mg/5mL should not be used by individuals with known hypersensitivity to zoledronic acid or any other bisphosphonates. It is also not recommended for use during pregnancy or breastfeeding. Patients with severe kidney impairment should use it with caution and under the supervision of a healthcare professional.